DNMT1 and cancer: As a partial cooperation between de novo and maintaining Dnmts have also been reported increasing methyl donors accessibility may palliate mMase defects in cancers mainly promoted by Dnmt1/PCNA/URHF1 disruption and limit further chromosomal instability and local hypomethylations.